Related by context. All words. (Click for frequent words.) 67 GRNOPC1 contains 66 kidney urologic 65 dose escalation phase 65 recurrent metastatic ovarian cancer 64 via intradermal injections 63 recurrent glioblastoma multiforme 63 granted Ortec 62 MAGE A3 ASCI 62 adipose derived stem cell 62 steroid refractory 61 radiolabeled TM# 61 Pegloticase 61 relapsed MM 61 recombinant PSMA vaccine 61 CURE AF 61 Recurrent Glioblastoma 61 Dementia Related Psychosis 61 Simulect 61 Phase IIb III 60 biliary tract cancer 60 HepaMate ™ 60 allogeneic bone marrow 60 asymptomatic hyperuricemia 60 NPM1 mutation 60 selective modulator 60 GERD migraine headaches 60 riociguat 60 Syndax Pharmaceuticals Inc. 60 hereditary deficiency 60 dose intramuscular 60 BrachySil TM 60 Confirmatory tests 60 polycythemia vera PV 60 immune globulins 60 Tumor Response 60 Hedgehog Pathway Inhibitor 60 HuMax TAC 60 #I TM# 60 MGd 60 primary immunodeficiency PI 59 subcutaneous PRO 59 myelofibrosis polycythemia vera 59 de novo kidney transplant 59 Initiate Clinical Trial 59 Nothing Wadden 59 subcutaneous methylnaltrexone 59 ADVEXIN therapy 59 DEEP AF 59 Certolizumab pegol 59 metastatic neuroendocrine tumors 59 Bayer HealthCare Onyx Pharmaceuticals 59 either acutely decompensated 59 Umbilical cord stem cells 59 immunomodulatory agents 59 Romiplostim 59 AFRS TM 59 busulfan 59 constipation OIC 59 NP2 Enkephalin 59 Cloretazine 59 ImmuKnow R 59 intravesical infusion therapy 59 Known hypersensitivity 59 Urocidin TM 59 Phase #b/#a clinical 59 vapreotide acetate 59 samalizumab 59 immune reconstitution syndrome 59 Cytolin 59 colorectal adenocarcinoma 58 Rilonacept 58 Virulizin ® 58 Tasigna prolongs 58 Liver transplantation 58 chronic thromboembolic pulmonary 58 oral ghrelin agonist 58 acetonide FA 58 Acute Decompensated Heart Failure 58 novel therapeutic antibodies 58 EXJADE 58 Pagoclone 58 Stereotactic Body Radiation Therapy 58 Acute Radiation Syndrome ARS 58 CMV reactivation 58 Gleevec resistant 58 Endotoxin Activity Assay 58 Heart Transplant Recipients 58 Severe Sepsis 58 AKT inhibitor 58 Venous thromboembolism 58 refractory CLL 58 blinded randomized placebo controlled 58 recombinant interferon 58 #beta estradiol 58 treatment naive genotype 58 number NCT# ClinicalTrials.gov 58 including eniluracil ADH 58 Diamyd r 58 cMET 58 Manja Bouman CEO 58 systemic invasive fungal 58 EDARBI 58 heparin induced thrombocytopenia 58 Enzastaurin 58 essential thrombocythemia ET 58 GI motility disorders 58 gastrointestinal stromal tumors GIST 58 Pafuramidine 58 allogeneic hematopoietic cell 58 POSIDUR TM 58 psoriatic arthritis PsA 58 humanized therapeutic 58 nosocomial pneumonia NP 58 SNT-MC#/idebenone 58 LHRH receptor positive 58 CYT# potent vascular disrupting 58 SUTENT ® 58 Lixivaptan 58 TACI Ig 58 multicenter Phase II 58 tetracycline antibiotic 58 Lymphocytic 58 Accelerated Partial Breast Irradiation 57 hypereosinophilic syndrome 57 acadesine 57 r hGH 57 fusion enhancers 57 tumor lysate 57 prospective nonrandomized 57 Hedgehog antagonist 57 Pyridorin 57 INS# [002] 57 polyomavirus nephropathy 57 Cathepsin B 57 Progressive Multifocal Leukoencephalopathy 57 CA9 SCAN 57 midstage clinical 57 Teriflunomide 57 dermatologic diseases 57 opioid bowel dysfunction 57 YONDELIS 57 UPLYSO 57 myelodysplastic myeloproliferative diseases 57 im peramivir 57 OncoVex 57 noninvasive outpatient 57 cardiac repolarization 57 poststroke depression 57 hepatorenal syndrome 57 Diabetic Foot Ulcer 57 oral methylnaltrexone 57 idiotype vaccines 57 achieved CCyR 57 advanced carcinoid 57 MVA MUC1 IL2 57 refractory indolent non 57 fosbretabulin 57 allogeneic hematopoietic stem cell 57 TransVax 57 cellular immunotherapy 57 Sudhir Agrawal D.Phil 57 trastuzumab Herceptin ® 57 Aggrastat ® tirofiban hydrochloride 57 cilengitide 57 HepaGam B 57 Dacogen injection 57 BHT DNA 57 percutaneous drainage 57 imexon 57 AA Amyloidosis 57 HCD# [002] 57 demonstrated antitumor activity 57 akinetic mutism 57 Acute renal failure 57 Poly ICLC 57 K ras mutations 57 Official canadian pharmacy 57 Vertex hepatitis C 57 trastuzumab DM1 T DM1 57 PR interval prolongation 57 HDL Selective Delipidation 57 DermaVir Patch 57 Pseudomonas aeruginosa infections 57 Balamuthia 57 DEFINITY R 57 PDE# inhibitors 57 BEXXAR Therapeutic Regimen 57 Golfer Ballesteros 57 Altera Nebulizer System 57 thetreatment 57 ABSSSI 57 RhuDex 57 PrevOnco 57 Monoclonal antibody 57 Dr. Assa Amit 57 thorough QT 57 novel VDA molecule 57 Prostate Px + 57 denileukin diftitox 57 dasatinib Sprycel ® 57 tramiprosate Alzhemed TM 56 NATRECOR ® 56 anaphylactic reactions bronchospasm 56 induce orthostatic hypotension 56 non cirrhotic portal 56 palifermin 56 Egrifta 56 SPRYCEL ® 56 Angiox ® 56 catheter occlusion 56 Cytolin ® 56 Acute Renal Failure 56 Antithrombin 56 HIV coinfected 56 Pernicious anemia 56 anagrelide 56 pretransplant 56 oral talactoferrin 56 papillary renal cell carcinoma 56 PROCHYMAL 56 novel emulsion formulation 56 Alequel 56 adrenocortical cancer 56 chronic ITP patients 56 Current Controlled Trials 56 human IgG1 monoclonal 56 Pausch blogged regularly 56 treatmentof 56 Fx #A 56 Hypotension 56 Sebelius Ample 56 Golimumab 56 ONCONASE R 56 VP# [004] 56 Trofex 56 EVIZON TM 56 empiric therapy 56 acute humoral rejection 56 severe hypercholesterolemia 56 Azacitidine 56 PrevOnco ™ 56 SinuNase TM 56 PhG alpha 1 56 hepatic insufficiency 56 SWHCS 56 benign prostatic hypertrophy BPH 56 eosinophilic pneumonia 56 Cethrin 56 Chronic Heart Failure 56 overactive bladder syndrome 56 alvespimycin 56 intradermal injections 56 TransMID TM 56 Prodarsan 56 hemodynamically unstable 56 SPRIX ® 56 pulmonary hypertension PH 56 DDP# 56 PI3K/Akt pathway inhibitor 56 primary hyperparathyroidism 56 potent cytotoxic 56 constipation predominant irritable bowel 56 Rheos System 56 benign prostatic hyperplasia enlarged 56 necrotizing pneumonia 56 opioid induced constipation OIC 56 Phase lll 56 hyperphenylalaninemia HPA due 56 Cytotoxic T 56 HEALTH CLINIC Interfaith 56 intra abdominal infections 56 EMPOWER ™ 56 CMV vaccine 56 E1 INT TM 56 Cloretazine VNP#M 56 pancreatic ductal 56 underlying vasculopathy 56 oligodendrocyte progenitor cells 56 nosocomial pneumonia 56 DaTscan 56 G#DT 56 lorvotuzumab mertansine 56 hemodynamically stable 56 argatroban 56 ACTIVE W 56 SomatoKine 56 fast skeletal troponin 56 beta globin gene 56 eprodisate Fibrillex TM 56 VITAL Trial 56 INVEGA ® 56 treat chronic sinusitis 56 monocytes macrophages 56 Dr. Gulfo 56 PU H# 56 pediatric Crohn disease 56 Diamyd R 56 sapacitabine CYC# 56 GRNVAC1 56 TransVax ™ 56 Hydroxyurea 56 blood clot dissolving 56 indolent follicular non 56 oral mTOR inhibitor 56 hypertension cardiovascular disease 55 Pemphigus 55 Warfarin Coumadin 55 ESBA# 55 Xcellerated T Cells 55 IAP inhibitor 55 APTIVUS ritonavir 55 IMC #B 55 transthyretin amyloidosis 55 clevidipine 55 Metabolic Disorder 55 Mark A. Sirgo 55 herpetic keratitis 55 Pharmacokinetics PK 55 biliary stones 55 COSIRA trial 55 naive HCV 55 MVax 55 Inc. OTCBB IRBS 55 LEVADEX ™ 55 rheumatic disorders 55 antituberculosis 55 Sirtex SIR Spheres microspheres 55 pafuramidine maleate 55 immune thrombocytopenic purpura 55 imatinib resistance 55 DCVax R 55 rindopepimut 55 exploratory Phase IIa 55 adipose derived stem cells 55 Kit CD# positive 55 EGS# 55 Stereotaxis System 55 dihydroergotamine mesylate DHE 55 tropism testing 55 BEZ# 55 biostatistical analysis 55 Interferon beta 55 Fodosine 55 oral rivaroxaban 55 Immunotherapeutic 55 elevated transaminases 55 dialed Ybarra 55 OvaRex MAb 55 cystic fibrosis chronic pancreatitis 55 Talabostat 55 transplantation HCT 55 malignant ascites 55 ALK inhibitors 55 BioNumerik 55 Catheter Associated 55 PRIMO CABG 55 cefprozil 55 hematopoietic progenitor cells 55 Vincristine 55 Archexin 55 dose proportionality 55 immune modulatory 55 debilitating neurodegenerative disorder 55 adult chronic ITP 55 phase Ib clinical 55 vinca alkaloid 55 rhIGF-I/rhIGFBP-3 55 gastrointestinal mucositis 55 transrectal ultrasound guided 55 tonsillar hypertrophy 55 anti TNFa 55 Dr. Ayalew Tefferi 55 immunocompetent 55 cardio renal 55 Vivaglobin 55 GLASS ART Trial 55 oral prodrug 55 Generx TM 55 ALN VSP Phase 55 CELVAPAN H#N# 55 Annamycin 55 Chronic Lyme disease 55 MSBT 55 containing LABAs 55 aMCI precursor 55 SYMMETRY trial 55 antiplatelet medications 55 Cardiotoxicity 55 erythema nodosum 55 Glucocorticoids 55 Dr. Miguel Valderrabano 55 paclitaxel poliglumex 55 Phase IIb clinical trials 55 rALLy clinical trial 55 medically inoperable 55 postexposure 55 CIMZIA TM certolizumab pegol 55 TransVax tm 55 SCENESSE ® 55 Nicole Onetto MD 55 Aviptadil 55 hematopoietic cancers 55 Degarelix 55 oxymorphone ER 55 refractory chronic lymphocytic 55 OncoVEX 55 vidofludimus 55 thoracoscopic lobectomy 55 COREG 55 Myelofibrosis 55 cytopenias 55 ELISPOT assay 55 ALN HTT 55 allogeneic HSCT 55 FibroScan ® 55 tumorigenicity 55 genomic biomarker 55 anti Parkinsonian 55 budesonide MMX Phase III 55 Targretin capsules 55 ISTODAX 55 Major Depressive Disorder MDD 55 pivotal bioequivalence 55 Antiviral medication 55 prokinetic agent 55 diagnostic molecular imaging 55 hyperplasia BPH 55 REGEN trial 55 CHAMPION PCI 55 Dr. Zelenetz 55 ABILIFY Injection 55 website http:/www.celsion.com 55 PANVAC VF 55 achieved sustained virologic 55 GW# [003] 55 Squalamine 55 rotary VAD 55 status epilepticus 55 Vascugel 55 erlotinib Tarceva 55 pancreatic neuroendocrine tumors 55 HER2 overexpression 55 VitiGam 55 LAB CGRP 55 PSMA ADC 55 Plicera 55 viral inactivation 55 subcutaneous immunoglobulin 55 adenosine A2A 55 LEAPS TM 55 orally inhaled migraine 55 Sanvar R 55 pyrimidine nucleoside analog 55 Exherin TM 55 Candida infection 55 anticholinergic agents 55 Epidermal Growth Factor Receptor 55 bolus dose 55 chemistry microbiology immunology 55 vivo toxicology 55 acute mania 55 metastatic malignant 55 Vascugel R 55 metabonomics 55 cortical dysplasia 54 Medidur ™ FA 54 neuroactive 54 acyclovir Lauriad R 54 subcutaneous ORENCIA 54 rheumatoid arthritis osteoarthritis ankylosing 54 Linjeta TM 54 SinuNase ™ 54 PROTEGE 54 TRAIL induced apoptosis 54 prevent reinfection 54 sunitinib Sutent 54 Bronchiectasis 54 anticancer therapeutics 54 torsade de pointes 54 Joshua Boger Ph.D. 54 hematological parameters 54 castrate resistant prostate cancer 54 Diffuse Large B 54 non nucleoside inhibitor 54 erlotinib Tarceva ® 54 malignant pleural effusion 54 MYCAMINE 54 coagulation assays 54 Fibrillex TM 54 inflammatory demyelinating 54 histamine dihydrochloride 54 TURBT 54 Neuvenge 54 Steven Galson MD MPH 54 initiate multicenter 54 Phase #b/#a 54 thalidomide Thalomid 54 delipidation 54 Vaxfectin TM formulated 54 Michael H. Tardugno 54 SIMPONI TM 54 dopamine receptor agonist 54 severe gastroparesis 54 deCODE ProstateCancer TM 54 Immune Globulin 54 alkylating agent 54 hoFH 54 Inc. PINKSHEETS MEDS 54 influenza neuraminidase 54 JAK2 enzyme 54 Triapine R 54 pneumocystis carinii pneumonia 54 curative therapy 54 Antitumor Activity 54 receptor tyrosine kinase inhibitor 54 receiving chemoradiation therapy 54 Antiangiogenic 54 inhaled AAT 54 mycosis fungoides 54 GED aPC 54 Phase Ib study 54 Myoblast 54 superficial basal cell carcinoma 54 irinotecan oxaliplatin 54 AGHD 54 idiopathic thrombocytopenic purpura 54 budesonide foam 54 weekly subcutaneous injections 54 epoprostenol 54 bi phasic 54 potassium chloride stops 54 oral picoplatin 54 INTERCEPT red 54 phase IIb clinical 54 Pulmonary Arterial Hypertension 54 Actimmune ® 54 PITX2 methylation 54 mg/m2 cohort 54 NPC 1C 54 proliferative disorders 54 huC# DM4 54 Glaxo rotavirus vaccine 54 transfusion syndrome 54 vernakalant hydrochloride 54 ZFP Therapeutics 54 cytomegalovirus infection 54 Rimantadine 54 Lumbar spinal stenosis 54 Nabi HB Intravenous 54 Dr. Cassian Yee 54 EDEMA3 trial 54 TNF antagonist 54 CALGB # [002] 54 Phase IIIb clinical 54 Urocortin 2 54 quantitative polymerase chain 54 LymphoStat B TM 54 florbetaben 54 histone deacetylase inhibitor 54 Soluble CD# 54 telomerase inhibition 54 RSD# oral 54 AlloMap testing 54 Phase #b/#a trial 54 Neoadjuvant 54 antiangiogenic agent 54 tanespimycin 54 prospectively stratified 54 HeartNet 54 Ecallantide 54 Elocalcitol 54 phase IIb trial 54 Ischemic 54 nitrofurantoin 54 myeloproliferative disorders 54 brivaracetam 54 STRIDE PD 54 theranostic 54 methylnaltrexone 54 intranasal formulation 54 RE MODEL 54 gastrointestinal stromal tumors GISTs 54 carcinoid syndrome 54 Afatinib 54 REMINYL ® 54 oral transmucosal 54 Celiac sprue 54 CDAD Clostridium difficile 54 herpes zoster shingles 54 Pertuzumab 54 Enkephalin 54 haematologic 54 opioid naïve 54 Heterozygous Familial Hypercholesterolemia 54 AE# vaccine 54 isavuconazole 54 candidemia 54 intraveneous 54 HQK 54 pathogenic mechanisms 54 protein tyrosine phosphatase 1B 54 GIST tumors 54 WX UK1 54 NCIC CTG 54 Urocidin 54 PEG SN# 54 X Excite 54 compressors turbo expanders 54 Fondaparinux 54 ADAGIO study 54 IMiDs ® compound 54 dopamine partial agonist 54 Specifid 54 pDCs 54 neuroregenerative 54 Curaxin 54 Tyrosine Kinase Inhibitors 54 Ventricular Tachycardia 54 #mg ATC 54 Nanobody R 54 Nasdaq ONXX today 54 subcutaneous formulation 54 forodesine hydrochloride 54 Surgical resection 54 pharmacodynamic parameters 54 cirrhotic CHC monoinfected patients 54 Angela Genge 54 eculizumab therapy 54 optimal dosing regimens 54 colorectal carcinoma 54 prostate carcinoma 54 Lymphoid 54 plasmacytoid 54 Sphingomab TM 54 recombinant tissue plasminogen 54 Islet transplantation 54 Biliary System 54 myeloproliferative diseases 54 Diabetic Neuropathy 54 Myelodysplastic Syndrome MDS 54 mediated inhibition 54 CINTREDEKIN BESUDOTOX 54 Induced pluripotent stem cells 54 polycythemia vera essential thrombocythemia 54 levodopa induced 54 DNA hypermethylation 54 Ectopia Cordis 54 Acute Exacerbations 54 BCR ABL inhibitor 54 pDC 54 ADVEXIN p# therapy 54 Glucocorticoid 54 phase Ib 54 OvaRex ® MAb 54 ENTB 54 IDH mutations 54 recombinant erythropoietin 54 Neurodex TM 54 BCG refractory 54 Alexza Staccato 54 LEUKINE 53 CBLC# 53 partner Lux Biosciences 53 potent antiproliferative 53 Combo Stent 53 erythropoietic 53 Dose adjustments 53 macular edema secondary 53 Idiopathic Pulmonary Fibrosis 53 BEXXAR 53 moderate hepatic impairment 53 perinatal morbidity 53 5 FU cytotoxic 53 post operative ileus 53 Phase 1b clinical trials 53 Kinoid 53 Etubics 53 efalizumab 53 treat opioid dependence 53 GCP compliant 53 alemtuzumab MS 53 generation purine nucleoside 53 Acute Coronary Syndromes ACS 53 chronic GVHD 53 vWD 53 topical hemostat 53 Exelixis XL# 53 Cerashield TM 53 intravenous tissue plasminogen 53 Bioral Amphotericin B 53 DAVANAT 53 cardiogenic 53 recurrent herpes labialis 53 immunomodulatory therapy 53 Insulin detemir 53 invasive aspergillosis 53 Lymph node 53 solid organ transplantation 53 novel immunotherapeutic 53 protamine sulfate 53 flavopiridol 53 SYN# 53 ancrod 53 oral antiplatelet agent 53 Meningiomas 53 balsalazide tablet 53 Européenne Mark 53 relapsed MCL 53 HBeAg + 53 lupus hepatitis C 53 Chronic Renal Failure 53 Nephrology Neurology 53 MEND CABG II 53 VANTAS ® 53 DXL# 53 Phase Ib II 53 AMEVIVE 53 Teresa Graedon Ph.D. 53 biocatalytic processes 53 systemic autoimmune 53 ToGA 53 Human cl 53 transcranial Doppler ultrasound 53 Initiate Phase II 53 multivalency 53 Chemophase 53 very badly Berlinschi 53 PHRM 53 Vidaza azacitidine 53 cytomegalovirus CMV retinitis 53 Plaque Psoriasis 53 Octreolin 53 tumor histology 53 somatostatin analogues 53 leukaemic stem cells 53 Transcranial Magnetic Stimulation TMS 53 Factor VIIa 53 RESTORE CLI trial 53 Investigational Treatment 53 multidose 53 NTDDS 53 HIV HCV coinfected 53 fibrotic disease 53 PEGylated interferon 53 Rancagua Cuban field 53 bronchoalveolar lavage BAL 53 CRMD# 53 Insulin PH# 53 Pulse oximetry 53 randomized discontinuation 53 Xanafide 53 experimentally induced 53 thrombin inhibiting aptamer 53 Endoscopic Ablation System 53 cerebral vasospasm 53 Dr. Annabelle Volgman 53 Glufosfamide 53 metastatic malignant melanoma 53 BLA filing 53 ANN INTERN MED 53 Anidulafungin 53 cardio metabolic diseases 53 chronic lyme 53 immunological diseases 53 octreotide implant 53 anthracyclines taxanes 53 intracellular pathway 53 Dr. Vitetta 53 Fabry Disease 53 Fibroblast 53 cardiology urology 53 Multiple Ascending Dose 53 Introgen ADVEXIN 53 PI3K Akt 53 CIMZIA TM 53 HCV antiviral 53 antibody mediated 53 Chronic Prostatitis 53 Sham acupuncture 53 endothelin receptor antagonists 53 Dr. Arndt Schottelius 53 Val HeFT 53 cytostatic 53 elacytarabine 53 ACCORD Eye 53 anti tubercular 53 oral RELISTOR 53 enzymatic pathways 53 treat narcolepsy 53 Bipolar Mania 53 pseudobulbar affect PBA 53 Pneumocystis carinii pneumonia 53 forodesine 53 epoetin alpha 53 visceral metastases 53 cystic fibrosis bronchiectasis 53 osteoporotic compression fractures 53 daptomycin 53 investigational biologic 53 HIF 1a 53 Gregg Allman undergoes 53 drug ISA# 53 photodynamic treatment 53 Elafin 53 Brussels THR 53 TMS Therapy 53 Teriparatide 53 Zemplar Capsules 53 primidone 53 Cand5 53 musculo skeletal spine 53 DAPT 53 Bacteremia 53 NOMID 53 ENABLE Phase 2 53 MCSP respectively 53 lymphomas leukemias 53 spokesman Heru Nogroho 53 Investigational Device Exemption 53 aurora kinase 53 Prospective Randomized 53 DF HCC 53 biologic DMARD 53 immune modulating 53 neuroinflammatory 53 Dr. Grekos 53 ACTEMRA TM 53 GSK# [001] 53 alpha antagonist 53 MultiGEN 53 TRAIL receptor antibody mapatumumab 53 SEQureDx ™ 53 HuMax EGFr 53 LATUDA 53 CIMZIA ™ 53 Traficet EN 53 iii GTx 53 Puricase PEG uricase 53 trans ISA# 53 KYNAPID 53 ischemia induced 53 nonalcoholic steatohepatitis NASH 53 MD PhD DSc 53 validating biomarkers 53 thorough QTc 53 voiding dysfunctions 53 immuno therapeutic 53 ghrelin leptin 53 systemic fungal infections 53 Phase #/#a 53 rectal suppository 53 p# biomarker 53 Metabolic Disease 53 AGILECT R 53 MetaCare 53 Zavesca R 53 Pemetrexed 53 Inhaled AAT 53 Leukemias 53 Recombinant interferon alpha 53 systemically administered 53 biomarker identification 53 replicon 53 VBLOC TM 53 HBV infections 53 Progenitor cells 53 Chronic pancreatitis 53 INVEGA ® SUSTENNA ® 53 SCIg 53 aerosolized surfactant 53 Immunosuppression 53 visit www.rtanswers.org 53 pharmacokinetic characteristics 53 Confirmatory testing 53 experimental allergic encephalomyelitis 53 ALN HPN 53 Hepatotoxicity 53 selective angiogenic kinase inhibitor 53 Acute myelogenous leukemia 53 Innate Immune 53 Luveris 53 Evoltra ® 53 Accelerating apoptosis may 53 ENJUVIA 53 Hodgkin lymphoma HL 53 TRO# 53 chemotherapy hormonal therapy 53 NeuroStar TMS Therapy 53 unresectable recurrent 53 hematopoietic cell 53 orally inhaled 53 non nucleoside HCV 53 canakinumab 53 vasoactive 53 antidepressants fluoxetine 53 lupus renal disease 53 Acute Liver Failure 53 prospective multicenter study 53 torsemide ER 52 Jean Pierre Routy 52 neurology immunology 52 allograft rejection 52 Sexsomnia 52 antiangiogenesis 52 tPA tissue plasminogen 52 neovascularisation 52 Tarceva TM 52 ritonavir boosted 52 faropenem medoxomil 52 QLT# 52 metastatic GIST 52 ATL# [001] 52 Dr. Kaminetsky 52 Recombinant Human 52 live attenuated intranasal 52 C1 INH deficiency 52 haematological malignancies 52 NOX E# 52 Cimzia TM 52 #beta HSD1 52 coadministration 52 VAPRISOL 52 orally administered inhibitor 52 Epiphany Biosciences 52 neuroendocrine cancers 52 Diamyd ® 52 biased ligand 52 Daniel Tasse 52 neoplastic diseases 52 Helixate FS 52 compare GVAX 52 phase IIb study 52 inactivated strain 52 vitro pharmacology 52 liver resection 52 hepatic metastases 52 acyclovir Lauriad ® 52 confirmatory clinical 52 APEX AMI 52 Cerebril TM 52 deactivating nerves 52 Acute Ischemic Stroke 52 Mutation Analysis 52 visit http:/www.clinicaltrials.gov/ 52 p# inhibitor 52 preclinically 52 antimicrobial prophylaxis 52 Combidex 52 distributing misbranded 52 BiTE R 52 rFVIIa 52 Schizophrenia Treatment 52 Dural Sealant 52 Amy Abernethy 52 small molecule macrocyclic 52 Circulatory Support 52 JAK2 inhibitor 52 modified REGENESIS Phase IIb 52 subcutaneous SC 52 GnRH agonists 52 EGFR tyrosine kinase inhibitors 52 Sezary syndrome 52 Ocrelizumab 52 Dabigatran etexilate 52 Gadavist 52 Panzem R NCD 52 secretagogues 52 Aurora kinase inhibitor 52 Hedgehog inhibitor 52 Aplidin 52 severe oral mucositis 52 hESC derived cardiomyocytes 52 chronic eosinophilic leukemia 52 lymphatic mapping 52 Percocet oxycodone 52 Antisoma AS# 52 mTOR mammalian target 52 oversulfated version 52 Ferring Pharmaceuticals privately 52 Spiro Rombotis President 52 human Chorionic Gonadotropin 52 hyperprolactinemia 52 Nanobody 52 HC APAP 52 Septin9 biomarker 52 SoftScan ® 52 Litx 52 ELND-#/AZD-# 52 PNP inhibitor 52 treating neuropathic pain 52 CO2 TMR 52 Surfaxin LS 52 Advaxis Phase 52 Hematopoietic 52 nasally administered 52 Nonalcoholic Steatohepatitis 52 gave Makena orphan 52 clonogenic 52 Vascugel ®